Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 15/20 | 0.46 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.43 |
| ▸ | BRD7 | Q9NPI1 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | NQO2 | P16083 | 1/20 | 0.38 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19685726 | 0.95 | BRD4 (0.42) | BRD4BRD9BRD7L3MBTL1KDM4E | |
| SCHEMBL19685731 | 0.87 | BRD4 (0.52) | BRD4BRD9BRD7KDM4E | |
| SCHEMBL19685723 | 0.84 | BRD4 (0.36) | BRD4BRD9BRD7L3MBTL1POLB | |
| SCHEMBL19686143 | 0.84 | KDM4E (0.43) | L3MBTL1KDM4ENQO2POLBATM | |
| SCHEMBL19685965 | 0.83 | MAOB (0.39) | L3MBTL1KDM4ENQO2ATM | |
| SCHEMBL19686032 | 0.82 | MAOB (0.40) | L3MBTL1KDM4ENQO2ATM | |
| SCHEMBL19686027 | 0.82 | BRD4 (0.49) | BRD4BRD9BRD7KDM4E | |
| SCHEMBL19686028 | 0.79 | APP (0.35) | BRD4BRD9BRD7L3MBTL1POLB | |
| SCHEMBL19686042 | 0.79 | KDM4E (0.42) | L3MBTL1KDM4ENQO2POLBATM | |
| SCHEMBL15999724 | 0.76 | MAPK1 (0.53) | L3MBTL1KDM4EPOLBATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10714693-B2 | Polycyclic compound and organic electroluminescence device including the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-07-14 | — | — | US | disclosed |
| US-20170352817-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | KYUSHU UNIVERSITY, NATIONAL UNIVERSITY CORPORATION (JP) | 2017-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10714693-B2 | Polycyclic compound and organic electroluminescence device including the same | CYC1, CCNA1, CYCS | BRD4 740/4885BRD9 1480/4885BRD7 2005/4885 |
| US-20170352817-A1 | POLYCYCLIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE INCLUDING THE SAME | CYC1, CCNA1, CYCS | BRD4 740/4885BRD9 1480/4885BRD7 2005/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.